Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverAPYX
HealthcareNMSUSD

Apyx Medical Corporation

$00123456789.0012345678900123456789+2.4%
52w low (est.) $3.02$5.05 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD171.39M
52w range
USD1.59 - USD5.08
Beta
1.37
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD1.63
Margin of safety
-58.4%
PEG ratio
0.59
Quality & efficiency
Moat score
35/100
Return on equity
-76.5%
Profit margin
-16.4%
Debt / equity
3.02
Growth & analysts
Revenue growth
+32.5%
Analyst target
USD6.60
Target upside
+68.4%
Analysts
5
Run the 10-point checklist before you buy How these numbers are made

About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Valuation

ValueGrowthProfitHealthIncome23QUALITY
Overall Rating
22
Sell
Sell

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score35
DCF Intrinsic Value
USD1.63-58.4% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD171.39M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+32.5%
Profit Margin
-16.4%
ROE
-76.5%
Debt / Equity
3.02
Beta
1.37
High Growth
vs Healthcare sector:Moat 35 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · APYX